Zacharoula Sidiropoulou: Pushing the Boundaries of Breast Surgical Oncology
Zacharoula Sidiropoulou, Senior Consultant Breast Surgical Oncologist at Hospital São Francisco Xavier, shared a post on LinkedIn:
“Pushing the Boundaries of Breast Surgical Oncology
Endoscopic nipple-sparing mastectomy is revolutionizing breast cancer treatment.
Since I only believe in God and everybody else must provide me with valid data (Gauthier Rathat) here they go:
Juhe 2025 meta-analysis,2,612 patients, demonstrates that endoscopic approaches achieve:
Equivalent oncological safety to conventional techniques (52-month follow-up)
Superior cosmetic outcomes with significantly improved patient satisfaction
Reduced complication rates: NAC necrosis as low as 4.9% vs traditional methods
Minimal invasive access with single incision techniques
Latest Evidence:
- 100% surgical completion rates in recent French cohort studies
- Overall complication rates of just 10.3% in single-center series of 88 procedures
- Local recurrence rates maintained at 1.6% with 24-month follow-up
- Mean operative time now standardized through systematic 7-step protocols
- The fusion of advanced endoscopic visualization with oncological precision is transforming what we can offer patients – preserving anatomy while maintaining the highest safety standards.
- The future of breast surgery is minimally invasive, maximally effective.
Hudge thank you to Gauthier Rathat all his invaluable team that in collaboration with the Applied Medical provided us such an insightful mentorship!”
More posts featuring Zacharoula Sidiropoulou on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023